A study to assess the efficacy of the multi-modal intervention on the severity of psychotic symptoms, medication adherence, and quality of life among schizophrenic patients admitted to a tertiary care hospital in Central India: A randomized Controlled trial
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 30
- 试验地点
- 1
研究概览
简要总结
Schizophrenia is linked to psychosis and significant challenges in personal, family, social, educational, and professional aspects of life. Individuals affected by schizophrenia often face stigma, discrimination, and human rights abuses. Unfortunately, despite the existence of appropriate care, a majority of people with psychosis worldwide—over two-thirds—lack access to specialized mental health services. On a positive note, with adequate treatment, about one-third of those diagnosed with schizophrenia can fully recover.
Given the significant challenges associated with schizophrenia, the researcher aims to develop a multi-model intervention. This strategy will evaluate the effectiveness of combining pharmacological therapy with non-pharmacological approaches to reduce psychotic symptoms, improve medication adherence, and enhance patients’ quality of life in tertiary care hospitals in India.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)(—)
- 性别
- All
入选标准
- •Understand Hindi or English
- •An established diagnosis of Schizophrenia based on ICD-11/ICD-
- •CGI-Severity score of less than or equal to 4
- •Stable Antipsychotic regimen for equal to or more than 4 weeks
- •Capacity to provide informed consent
- •Medical Clearance for moderate activity.
排除标准
- •CGI-S score between 5 and 7
- •Alcohol or drug dependence within the last 6 months
- •Active suicidal ideation or attempt in the last 6 months
- •Uncontrolled hypertension, severe cardiac disease, epilepsy, or significant head trauma.
研究者
Dr Rajratan
All India Institute of Medical Sciences Bhopal
